Mold-Tek Packaging Ltd (MOLDTKPAC) Q2FY27 Concall Summary - Sep-2026 Qtr
Key Takeaways
- Management reaffirmed its full-year EBITDA guidance of INR 215 crores, signaling confidence in maintaining a high EBITDA per kg of INR 45-46.
- The long-delayed Iodex balm pack project has been cleared and will commence commercial production in December or January, adding millions of units monthly.
- The 'Wybe' specialty closures partnership is set for commercial production in FY28, targeting INR 50-60 crores in revenue within three years with high margins.
Performance Overview
- The company reported a strong quarter with a 10.1% year-over-year increase in sales volume.
- Profitability saw a significant jump of 36% compared to the same quarter last year, driven by a better product mix.
- The Food & FMCG and Pharma segments were the primary growth drivers, with volume increases of 23.7% and 26.3% respectively.
- The lubricants segment continued to underperform, recording a 12.3% decline in volume.
- Operational efficiencies improved due to the consolidation of IML label production in Hyderabad and the clubbing of other production units.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.
Tone & Disclosure
Log in to Stocksigma to read the Tone & Disclosure section of this summary.